ACE inhibitor treatment for COVID-19 patients
Treatments studied
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This trial studies whether taking an ACE inhibitor medicine can help people who currently have COVID-19. You may be considered if you have COVID-19 and can safely take this type of medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a current COVID-19 infection.
- You have no known allergy to ACE inhibitor medicines.
- You do not have a medical reason you cannot take ACE inhibitor medicines (a contraindication).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies new drug treatment plans for people who currently have COVID-19. If it works better than standard care, it could improve recovery for patients.
This trial studies whether a higher dose of ivermectin helps people with COVID-19. It looks at how well the treatment works and whether it causes side effects for participants.
This study looks at how the COVID-19 outbreak affected care for people admitted to the cardiac intensive care unit. It may help hospitals improve how they plan and respond during major outbreaks.
This trial looks at how persistent heart-related changes after a past COVID infection may be affected by study treatments. It mainly seeks people who are stable enough for follow-up visits and heart imaging, and who are not already on the specific heart medications required.
This study looks at people who were admitted to the hospital in Terrassa starting in March 2020. Researchers want to see whether having a flu vaccine and using certain blood-pressure medicines (ACE inhibitors or ARBs) is linked to how COVID infection develops.
This study looks at how ongoing antihistamines or amantadine treatment affects the course of COVID-19. If you already take one of these medicines regularly, the study may help understand whether it offers any benefit.
Hear when a new COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.